Ciliary Neurotrophic FactorAx15 Alters Energy Homeostasis, Decreases Body Weight, and Improves Metabolic Control in Diet-Induced Obese and UCP1-DTA Mice
- Susann Blüher1,
- Stergios Moschos1,
- John Bullen, Jr.1,
- Efi Kokkotou2,
- Eleftheria Maratos-Flier2,
- Stanley J. Wiegand3,
- Mark W. Sleeman3 and
- Christos S. Mantzoros1
- 1Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
- 2Joslin Diabetes Center, Harvard Medical School, Research Division, Boston, Massachusetts
- 3Regeneron Pharmaceuticals, Tarrytown, New York
- Address correspondence and reprint requests to Susann Blüher, Beth Israel Deaconess Medical Center, Harvard Medical School, 99 Brookline Ave., Boston, MA 02215. E-mail: sblueher{at}caregroup.harvard.edu
Abstract
Ciliary neurotrophic factor (CNTF) potently reduces appetite and body weight in rodents and humans. We studied the short- and long-term effects of CNTFAx15, a second-generation CNTF analog, in diet-induced obese C57BL/6J mice and brown adipose tissue (BAT)-deficient obese UCP1-DTA (uncoupling protein 1–diphtheria toxin A) mice. CNTFAx15 administration (0.1, 0.3, or 1.0 μg · g−1 · day−1 s.c.) for 3 or 7 days reduced food intake and body weight (mainly body fat mass). The effect of CNTFAx15 on food intake and body weight was more pronounced in CNTFAx15-treated diet-induced obese C57BL/6J mice compared with pair-fed controls and was associated with suppressed expression of hypothalamic neuropeptide Y and agouti gene–related protein. Moreover, CNTFAx15 increased uncoupling protein 1 mRNA expression in BAT and energy expenditure in diet-induced obese C57BL/6J mice. Longitudinal observations revealed a sustained reduction in body weight for several days post-CNTFAx15 treatment of CNTFAx15-treated but not pair-fed mice, followed by a gradual regain in body weight over 28 days. Finally, CNTFAx15 administration improved the metabolic profile in both diet-induced obese C57BL/6J and UCP1-DTA mice and resulted in a significantly improved glycemic response to oral glucose tolerance tests in CNTFAx15-treated UCP1-DTA compared with pair-fed mice of similar body weight. These data suggest that CNTFAx15 may act through a pathway downstream of the putative point responsible for leptin resistance in diet-induced obese C57BL/6J and UCP1-DTA mice to alter food intake, body weight, body composition, and metabolism. CNTFAx15 has delayed and persistent effects in diet-induced obese C57BL/6J mice, which account for a reduction in body weight over and above what would be expected based on decreased foot intake alone.
- AgRP, agouti gene–related protein
- BAT, brown adipose tissue
- CNTF, ciliary neurotrophic factor
- NPY, neuropeptide Y
- OGTT, oral glucose tolerance test
- POMC, proopiomelanocortin
- UCP1, uncoupling protein 1
Footnotes
-
Additional information for this article can be found in an online appendix at http://diabetes.diabetesjournals.org.
-
- Accepted July 8, 2004.
- Received February 11, 2004.
- DIABETES














